Annual EBITDA
-$30.49 M
-$19.46 M-176.49%
December 31, 2021
Summary
- As of February 7, 2025, STAB annual EBITDA is -$30.49 million, with the most recent change of -$19.46 million (-176.49%) on December 31, 2021.
- During the last 3 years, STAB annual EBITDA has fallen by -$27.67 million (-983.34%).
- STAB annual EBITDA is now -983.34% below its all-time high of -$2.81 million, reached on December 31, 2019.
Performance
STAB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.35 M
+$1.37 M+50.24%
September 30, 2022
Summary
- As of February 7, 2025, STAB quarterly EBITDA is -$1.35 million, with the most recent change of +$1.37 million (+50.24%) on September 30, 2022.
- Over the past year, STAB quarterly EBITDA has increased by +$8.15 million (+85.75%).
- STAB quarterly EBITDA is now -121.39% below its all-time high of -$611.90 thousand, reached on March 1, 2020.
Performance
STAB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$18.61 M
+$8.15 M+30.45%
September 30, 2022
Summary
- As of February 7, 2025, STAB TTM EBITDA is -$18.61 million, with the most recent change of +$8.15 million (+30.45%) on September 30, 2022.
- Over the past year, STAB TTM EBITDA has increased by +$6.76 million (+26.64%).
- STAB TTM EBITDA is now -2941.92% below its all-time high of -$611.90 thousand, reached on March 1, 2020.
Performance
STAB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
STAB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -176.5% | +85.8% | +26.6% |
| 3 y3 years | -983.3% | -121.4% | -2941.9% |
| 5 y5 years | -983.3% | -121.4% | -2941.9% |
STAB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +83.2% | at high | +38.7% |
| 5 y | 5-year | -983.3% | at low | -121.4% | +85.8% | -2941.9% | +38.7% |
| alltime | all time | -983.3% | at low | -121.4% | +85.8% | -2941.9% | +38.7% |
Statera Biopharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$1.35 M(-50.2%) | -$18.61 M(-30.5%) |
| Jun 2022 | - | -$2.72 M(-58.1%) | -$26.76 M(-11.9%) |
| Mar 2022 | - | -$6.49 M(-19.3%) | -$30.36 M(+4.5%) |
| Dec 2021 | -$30.49 M | -$8.04 M(-15.4%) | -$29.06 M(+14.5%) |
| Sep 2021 | - | -$9.50 M(+50.4%) | -$25.37 M(+16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$6.32 M(+21.7%) | -$21.81 M(+40.8%) |
| Mar 2021 | - | -$5.19 M(+19.3%) | -$15.49 M(+42.0%) |
| Dec 2020 | -$11.03 M(+291.8%) | -$4.35 M(-26.8%) | -$10.91 M(+66.4%) |
| Sep 2020 | - | -$5.95 M(+871.9%) | -$6.56 M(+971.9%) |
| Mar 2020 | - | -$611.90 K | -$611.90 K |
| Dec 2019 | -$2.81 M | - | - |
FAQ
- What is Statera Biopharma annual EBITDA?
- What is the all time high annual EBITDA for Statera Biopharma?
- What is Statera Biopharma annual EBITDA year-on-year change?
- What is Statera Biopharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Statera Biopharma?
- What is Statera Biopharma quarterly EBITDA year-on-year change?
- What is Statera Biopharma TTM EBITDA?
- What is the all time high TTM EBITDA for Statera Biopharma?
- What is Statera Biopharma TTM EBITDA year-on-year change?
What is Statera Biopharma annual EBITDA?
The current annual EBITDA of STAB is -$30.49 M
What is the all time high annual EBITDA for Statera Biopharma?
Statera Biopharma all-time high annual EBITDA is -$2.81 M
What is Statera Biopharma annual EBITDA year-on-year change?
Over the past year, STAB annual EBITDA has changed by -$19.46 M (-176.49%)
What is Statera Biopharma quarterly EBITDA?
The current quarterly EBITDA of STAB is -$1.35 M
What is the all time high quarterly EBITDA for Statera Biopharma?
Statera Biopharma all-time high quarterly EBITDA is -$611.90 K
What is Statera Biopharma quarterly EBITDA year-on-year change?
Over the past year, STAB quarterly EBITDA has changed by +$8.15 M (+85.75%)
What is Statera Biopharma TTM EBITDA?
The current TTM EBITDA of STAB is -$18.61 M
What is the all time high TTM EBITDA for Statera Biopharma?
Statera Biopharma all-time high TTM EBITDA is -$611.90 K
What is Statera Biopharma TTM EBITDA year-on-year change?
Over the past year, STAB TTM EBITDA has changed by +$6.76 M (+26.64%)